Our immune system protects us throughout life – usually against infection, but also against our own cells, should they become ill or act abnormally.
It is known that the immune system can eliminate cancer cells! Two types of cells are particularly important, the Cytotoxic T cells (CTL) and Natural Killer (NK) cells.
Cytovac’s ALECSAT treatment is an immunotherapy and together with the most efficient weapon – namely the body’s own unique defense system – it is used to treat the disease.
The ALECSAT treatments is specifically designed for the individual patient and contains only the patient’s own activated cells.
Problem: Cancer patients have a suppressed immune system and lack these cells to fight the cancer.
Solution: Provide patients with NK cells and Cytotoxic T cells that are produced and activated ex-vivo.
Owing to the unique technology, developed by Cytovac, it is feasible to isolate, activate and grow selected cells from the patient’s own immune system. These activated cells will then be returned by injection to the same cancer patient.
When these cells are reinjected into the cancer patient, some of the cells will specifically attack the cancer cells, and other cells in the ALECSAT product will help to restore the patient’s immune system.
This may enable the immune system to win the battle against cancer.